References
Cascinelli N, Morabito A, Santinami M, et al. (1998) Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomized trial; WHO melanoma programme. Lancet 351:793–796
Balch CM, Soong S, Ross MI, et al. (2000) Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm): Intergroup Melanoma Surgical Trial. Ann Surg Oncol 7: 87–97
Ishihara K, Saida T, Otsuka F, et al. (2008) Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update. Int J Clin Oncol 13:33–41
Morton DL, Wen DR, Wong JH, et al. (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392–399
Cochran AJ, Roberts, AA, Saida, T, et al. (2003) The place of lymphatic mapping and sentinel node biopsy in oncology. Int J Clin Oncol 8:139–150
Medalie N, Ackerman AB (2004) Sentinel node biopsy has no benefit for patients whose primary cutaneous melanoma has metastasized to a lymph node and therefore should be abandoned now. Br J Dermatol 151:298–307
Fecher LA, Flaherty KT (2009) Where are we with adjuvant therapy of stage III and IV melanoma in 2009? J Natl Compr Canc Netw 7:295–304
Morton DL, Thompson JF, Cochran AJ, et al. (2006) Sentinelnode biopsy or nodal observation in melanoma. N Engl J Med 355: 1307–1317
Russell-Jones R (2005) Sentinel node and survival in melanoma. Br J Dermatol 153:1093–1095
González U (2007) Cloud over sentinel node biopsy: unlikely survival benefit in melanoma. Arch Dermatol 143:775–776
Johnson, TM, Sondak, VK, Bichakjian, CK, et al. (2006) The role of sentinel lymph node biopsy for melanoma: evidence assessment. J Am Acad Dermatol 54:19–27
Cochran AJ, Morton DL, Stern S, et al. (2001) Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: implications for tumor biology and treatment. Mod Pathol 14:604–608
Lee JH, Torisu-Itakara H, Cochran AJ, et al. (2005) Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes. Clin Cancer Res 11: 107–112
Balch CM, Buzaid AC, Soong SJ, et al. (2001) Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635–3648
Moroi Y (2009) Significance of sentinel lymph node biopsy in malignant melanoma: overview of international data. Int J Clin Oncol 14:485–489
Uhara H, Takata M, Saida T (2009) Sentinel lymph node biopsy in Japan. Int J Clin Oncol 14:490–496
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Saida, T. Sentinel lymph node biopsy in melanoma management: its significance and potential problems. Int J Clin Oncol 14, 483–484 (2009). https://doi.org/10.1007/s10147-009-0940-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-009-0940-1